A clinical trial of the anti-malaria drug hydroxychloroquine in coronavirus patients has been suspended amid safety concerns.
The drug has been touted by President Donald Trump and he even revealed he took the medication for two weeks as a prophylactic.
But the World Health Organization (WHO) said it was concerned after a study from The Lancet published on Friday revealed higher mortality rates among COVID-19 patients who took the drug.
Therefore, researchers said they’re suspending the use of hydroxychloroquine in the WHO’s Solidarity Trial, which is to evaluate the safety and efficacy of four drugs and drug combinations against the virus.
‘The executive group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity trial while the safety data is reviewed by the data safety monitoring board,’ WHO Director-General Tedros Adhanom Ghebreyesus said on Monday.
However, the other arms of the trial are continuing.
A Nigerian man who claims to know the UNIZIK lecturer assaulted by a student has weighed in on the controversy,… Read More
Nedu Wazobia is receiving backlash on social media after a recent comment from Verydarkman. This comes after VDM reacted to… Read More
A Nigerian student has shared troubling information on social media about her classmates damaging her reputation. In a detailed post… Read More
A Nigerian married woman has urged single ladies to thank God for being unmarried, sharing her personal story. In an… Read More
Deeone, is asking to go to court with well-known online activist Verydarkman. Recall that Deeone claimed on Nedu's HonestBunch podcast… Read More
Cardi B, impressed her fans by showcasing the bodycon dress she wore at the Super Bowl. She was styled by… Read More
This website uses cookies.